Optceutics Ltd has developed an innovative ocular model (PK-Eye) to accelerate ophthalmic drug development of protein-based and small molecules for the posterior segment of the eye. The PK-Eye is a two-compartment model that mimics the dimensions, mass transfer, aqueous outflow and clearance from the posterior segment. It has shown utility for (i) the rapid and accurate evaluation of proprietary third party formulations and (ii) accelerating pre-formulation studies for new intraocular medicines. The PK-Eye is used to potentially avoid non-human primate studies (especially for biosimilar development) and to design clinical protocols at the most appropriate dose are paramount for clinical development.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 29-39 Brunswick Square, London,england Wc1n 1ax,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- optceutics.com
- Keywords
- Ophthalmic drug development, Preclinical development, R&D, Opthalmology, Pharmaceutical modeling, Pharmaceutics, Biologics.
- HQ
- London, England
Optceutics Limited Questions
Optceutics Limited's website is optceutics.com
Optceutics Limited's LinkedIn profile is https://uk.linkedin.com/company/optceutics-limited
Optceutics Limited has
5 employees.
View email and phone details for 5
employees at Optceutics Limited.
Optceutics Limited's industry is
Biotechnology Research
Optceutics Limited's top competitors are
Analytik Jena Uk,
Kapodistrian Dermapharm Pc,
Biome Technologies Pvt Ltd,
Pear Bio,
Technolab — Greece,
Noroneke Consulting,
Medtechone,
P&c Solutions,
Apeikon Therapeutics,
Revive Innovations +.
Optceutics Limited's categories are Biotechnology Research
Optceutics Limited's founding year is 2016
